Prostaglandin expression profile in hypoxic osteoblastic cells

Christina M. Lee, Damian C Genetos, Alice Wong, Clare E Yellowley-genetos

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Conditions such as fracture and unloading have been shown to be associated with tissue and cellular hypoxia in bone. The effects of hypoxia on bone cell physiology and ultimately its impact on bone tissue repair and remodeling are not well understood. In this study, we investigated the role of hypoxia on prostaglandin release from osteoblastic cells cultured in 2% (hypoxia), 5% (potentially cellular normoxia), and 21% (normoxia for standard cell culture conditions) oxygen for up to 24 h. We quantified the effects of reduced oxygen tension on the release of prostaglandin (PG)E2, PGF , PGD2, and PGI2. The mechanism by which hypoxia increases PG production was investigated by examining the various regulatory components of the PG biosynthetic pathway. Our data show that PGE2 levels alone are significantly elevated under hypoxic conditions. Also, we show that cyclooxygenase (COX)-1 and COX-2 play an important role in hypoxia-induced PGE2 production, possibly via a mechanism involving changes in their respective activity levels under low oxygen conditions. The effect of hypoxia on PGE2 levels was mimicked by dimethyloxaloglycine, a known activator of the HIF pathway. In addition, we confirmed that HIF-1α was stabilized in osteoblastic cells under hypoxia. Taken together these data suggest a role for the HIF pathway in regulation of PGE2 levels under hypoxic conditions. Previous studies have detected release of prostaglandins from areas of damaged bone, such as a fracture site, and our data may contribute to an understanding of how this release is regulated.

Original languageEnglish (US)
Pages (from-to)8-16
Number of pages9
JournalJournal of Bone and Mineral Metabolism
Volume28
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Prostaglandins
Dinoprostone
Bone and Bones
Cell Hypoxia
Oxygen
Prostaglandin D2
Cell Physiological Phenomena
Cyclooxygenase 1
Bone Remodeling
Biosynthetic Pathways
Prostaglandins F
Epoprostenol
Cyclooxygenase 2
Hypoxia
Cultured Cells
Cell Culture Techniques

Keywords

  • Bone
  • Cyclooxygenase
  • Hypoxia
  • Osteoblastic cells
  • Prostaglandins

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Prostaglandin expression profile in hypoxic osteoblastic cells. / Lee, Christina M.; Genetos, Damian C; Wong, Alice; Yellowley-genetos, Clare E.

In: Journal of Bone and Mineral Metabolism, Vol. 28, No. 1, 01.2010, p. 8-16.

Research output: Contribution to journalArticle

@article{5ece1590572d4faea55c8ece8448b739,
title = "Prostaglandin expression profile in hypoxic osteoblastic cells",
abstract = "Conditions such as fracture and unloading have been shown to be associated with tissue and cellular hypoxia in bone. The effects of hypoxia on bone cell physiology and ultimately its impact on bone tissue repair and remodeling are not well understood. In this study, we investigated the role of hypoxia on prostaglandin release from osteoblastic cells cultured in 2{\%} (hypoxia), 5{\%} (potentially cellular normoxia), and 21{\%} (normoxia for standard cell culture conditions) oxygen for up to 24 h. We quantified the effects of reduced oxygen tension on the release of prostaglandin (PG)E2, PGF 2α, PGD2, and PGI2. The mechanism by which hypoxia increases PG production was investigated by examining the various regulatory components of the PG biosynthetic pathway. Our data show that PGE2 levels alone are significantly elevated under hypoxic conditions. Also, we show that cyclooxygenase (COX)-1 and COX-2 play an important role in hypoxia-induced PGE2 production, possibly via a mechanism involving changes in their respective activity levels under low oxygen conditions. The effect of hypoxia on PGE2 levels was mimicked by dimethyloxaloglycine, a known activator of the HIF pathway. In addition, we confirmed that HIF-1α was stabilized in osteoblastic cells under hypoxia. Taken together these data suggest a role for the HIF pathway in regulation of PGE2 levels under hypoxic conditions. Previous studies have detected release of prostaglandins from areas of damaged bone, such as a fracture site, and our data may contribute to an understanding of how this release is regulated.",
keywords = "Bone, Cyclooxygenase, Hypoxia, Osteoblastic cells, Prostaglandins",
author = "Lee, {Christina M.} and Genetos, {Damian C} and Alice Wong and Yellowley-genetos, {Clare E}",
year = "2010",
month = "1",
doi = "10.1007/s00774-009-0096-0",
language = "English (US)",
volume = "28",
pages = "8--16",
journal = "Journal of Bone and Mineral Metabolism",
issn = "0914-8779",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Prostaglandin expression profile in hypoxic osteoblastic cells

AU - Lee, Christina M.

AU - Genetos, Damian C

AU - Wong, Alice

AU - Yellowley-genetos, Clare E

PY - 2010/1

Y1 - 2010/1

N2 - Conditions such as fracture and unloading have been shown to be associated with tissue and cellular hypoxia in bone. The effects of hypoxia on bone cell physiology and ultimately its impact on bone tissue repair and remodeling are not well understood. In this study, we investigated the role of hypoxia on prostaglandin release from osteoblastic cells cultured in 2% (hypoxia), 5% (potentially cellular normoxia), and 21% (normoxia for standard cell culture conditions) oxygen for up to 24 h. We quantified the effects of reduced oxygen tension on the release of prostaglandin (PG)E2, PGF 2α, PGD2, and PGI2. The mechanism by which hypoxia increases PG production was investigated by examining the various regulatory components of the PG biosynthetic pathway. Our data show that PGE2 levels alone are significantly elevated under hypoxic conditions. Also, we show that cyclooxygenase (COX)-1 and COX-2 play an important role in hypoxia-induced PGE2 production, possibly via a mechanism involving changes in their respective activity levels under low oxygen conditions. The effect of hypoxia on PGE2 levels was mimicked by dimethyloxaloglycine, a known activator of the HIF pathway. In addition, we confirmed that HIF-1α was stabilized in osteoblastic cells under hypoxia. Taken together these data suggest a role for the HIF pathway in regulation of PGE2 levels under hypoxic conditions. Previous studies have detected release of prostaglandins from areas of damaged bone, such as a fracture site, and our data may contribute to an understanding of how this release is regulated.

AB - Conditions such as fracture and unloading have been shown to be associated with tissue and cellular hypoxia in bone. The effects of hypoxia on bone cell physiology and ultimately its impact on bone tissue repair and remodeling are not well understood. In this study, we investigated the role of hypoxia on prostaglandin release from osteoblastic cells cultured in 2% (hypoxia), 5% (potentially cellular normoxia), and 21% (normoxia for standard cell culture conditions) oxygen for up to 24 h. We quantified the effects of reduced oxygen tension on the release of prostaglandin (PG)E2, PGF 2α, PGD2, and PGI2. The mechanism by which hypoxia increases PG production was investigated by examining the various regulatory components of the PG biosynthetic pathway. Our data show that PGE2 levels alone are significantly elevated under hypoxic conditions. Also, we show that cyclooxygenase (COX)-1 and COX-2 play an important role in hypoxia-induced PGE2 production, possibly via a mechanism involving changes in their respective activity levels under low oxygen conditions. The effect of hypoxia on PGE2 levels was mimicked by dimethyloxaloglycine, a known activator of the HIF pathway. In addition, we confirmed that HIF-1α was stabilized in osteoblastic cells under hypoxia. Taken together these data suggest a role for the HIF pathway in regulation of PGE2 levels under hypoxic conditions. Previous studies have detected release of prostaglandins from areas of damaged bone, such as a fracture site, and our data may contribute to an understanding of how this release is regulated.

KW - Bone

KW - Cyclooxygenase

KW - Hypoxia

KW - Osteoblastic cells

KW - Prostaglandins

UR - http://www.scopus.com/inward/record.url?scp=76949084049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76949084049&partnerID=8YFLogxK

U2 - 10.1007/s00774-009-0096-0

DO - 10.1007/s00774-009-0096-0

M3 - Article

C2 - 19471853

AN - SCOPUS:76949084049

VL - 28

SP - 8

EP - 16

JO - Journal of Bone and Mineral Metabolism

JF - Journal of Bone and Mineral Metabolism

SN - 0914-8779

IS - 1

ER -